Explained in plain English

What is Trontinemab?

Trontinemab is an experimental drug made by Roche, a Swiss company. It's designed to target harmful proteins in the brain, which are thought to play a key role in the development of Alzheimer's. This trial will test if it can effectively block the disease's progression in people who haven't yet shown symptoms.